Evidence map›Paper›PMID 33652597›Full record

ArticleViruses2021

The Atypical Kinase RIOK3 Limits RVFV Propagation and Is Regulated by Alternative Splicing.

Katherine E Havranek, Luke Adam White, Thomas C Bisom, Jean-Marc Lanchy, J Stephen Lodmell

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katherine E HavranekDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
Luke Adam WhiteDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
Thomas C BisomDepartment of Chemistry and Biochemistry, University of Montana, Missoula, MT 59812, USA.
Jean-Marc LanchyDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
J Stephen LodmellDivision of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
University of Montana · US

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP20GM103546 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2012 to 2021
$19.2M
ASCEND, Accelerating Solutions for Commercialization and Entrepreneurial Development in the Mountain West IDeA StatesUT2GM130166 · NIGMS · VIRTICI, LLC · PI FANGER, NEIL A · 2018 to 2020
$3.6M
Mechanism of RVFV nucleocapsid targeting drugsR15AI105737 · NIAID · UNIVERSITY OF MONTANA · PI LODMELL, J. STEPHEN · 2014 to 2014
$432k
Role of the atypical protein kinase RIOK3 in the cellular antiviral responseR03TR002937 · NCATS · UNIVERSITY OF MONTANA · PI LODMELL, J. STEPHEN · 2019 to 2019
$143k
NCATS NIH HHS R03 TR002937NCATS NIH HHS R03TR002937NIAID NIH HHS R15 AI105737NIGMS NIH HHS P20 GM103546NIGMS NIH HHS UT2 GM130166NIH HHS P20GM103546NIH HHS R15AI105737
6 · The paper itself

Abstract

In recent years, transcriptome profiling studies have identified changes in host splicing patterns caused by viral invasion, yet the functional consequences of the vast majority of these splicing events remain uncharacterized. We recently showed that the host splicing landscape changes during Rift Valley fever virus MP-12 strain (RVFV MP-12) infection of mammalian cells. Of particular interest, we observed that the host mRNA for Rio Kinase 3 (RIOK3) was alternatively spliced during infection. This kinase has been shown to be involved in pattern recognition receptor (PRR) signaling mediated by RIG-I like receptors to produce type-I interferon. Here, we characterize RIOK3 as an important component of the interferon signaling pathway during RVFV infection and demonstrate that RIOK3 mRNA expression is skewed shortly after infection to produce alternatively spliced variants that encode premature termination codons. This splicing event plays a critical role in regulation of the antiviral response. Interestingly, infection with other RNA viruses and transfection with nucleic acid-based RIG-I agonists also stimulated RIOK3 alternative splicing. Finally, we show that specifically stimulating alternative splicing of the RIOK3 transcript using a morpholino oligonucleotide reduced interferon expression. Collectively, these results indicate that RIOK3 is an important component of the mammalian interferon signaling cascade and its splicing is a potent regulatory mechanism capable of fine-tuning the host interferon response.

Indexed as

Alternative SplicingAnimalsCell LineChlorocebus aethiopsGene Expression ProfilingHEK293 CellsHumansInterferon Type IProtein Serine-Threonine KinasesRift Valley FeverRift Valley fever virusSignal TransductionVero CellsViral Nonstructural ProteinsVirulence FactorsVirus ReplicationInterferon Type IProtein Serine-Threonine KinasesRIO kinase 3, humanViral Nonstructural ProteinsVirulence Factorsalternative splicinginnate immune responsemorpholino oligonucleotideMP-12Rift Valley fever virusRIOK3

Identifiers

PMID33652597
PMCPMC7996929
OpenAlexW3129939764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.